首页 > 最新文献

Nefrologia最新文献

英文 中文
Impacto percibido de la donación en vivo en una unidad de hemodiálisis de un centro no trasplantador 活体捐赠对非移植中心血液透析单位的感知影响
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.nefro.2022.12.003
{"title":"Impacto percibido de la donación en vivo en una unidad de hemodiálisis de un centro no trasplantador","authors":"","doi":"10.1016/j.nefro.2022.12.003","DOIUrl":"10.1016/j.nefro.2022.12.003","url":null,"abstract":"","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 4","pages":"Pages 586-588"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699522001989/pdfft?md5=42a98d3445246161598fd7268d513ec5&pid=1-s2.0-S0211699522001989-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48971990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cribado de infecciones tropicales e importadas en candidatos a trasplante renal migrantes desde la consulta de acceso al trasplante renal 从肾移植就诊咨询中筛查移民肾移植候选者的热带和输入性感染
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.nefro.2023.10.001

Background and objective

Kidney transplantation (KT) should be postponed in those people with active bacterial, fungal, viral and parasitic processes, since these must be treated and resolved previously. The objective of this study is to present the screening circuit implemented by the Nephrology clinic and describe the prevalence of tropical and imported infections in KT candidates born or coming from endemic areas.

Materials and methods

Descriptive cross-sectional study, carried out in 2021. Sociodemographic and clinical variables, serological data of general infections and specific tests of tropical infectious diseases were collected. A descriptive analysis of the data was carried out.

Results

Sixty seven TR candidates from Latin America (32.8%), North Africa (22.4%), Sub-Saharan Africa (14.9%) and Asia (29.9%) were included. 68.7% were men and the mean age was 48.9 ± 13.5 years. After the general and specific studies, 42 (62.7%) patients were referred to the Infectious Diseases Service to complete this study or indicate treatment. 35.8% of the patients had eosinophilia, and in one case parasites were detected in feces at the time of the study. Serology for strongyloidiasis was positive in 18 (26.9%) cases, while positive serology for other tropical infections was hardly detected. 34.3% of patients had latent tuberculosis infection.

Conclusions

The prevalence of tropical and imported infections in migrant candidates for RT was low, except for strongyloidiasis and latent tuberculosis infection. Its detection and treatment are essential to avoid serious complications in post-TR. To this end, the implementation of an interdisciplinary screening program from the KT access consultation is feasible, necessary and useful.

背景和目的对于患有活动性细菌、真菌、病毒和寄生虫感染的患者,应推迟进行肾移植(KT),因为必须先治疗和解决这些问题。本研究的目的是介绍肾脏病诊所实施的筛查电路,并描述出生在或来自流行地区的肾移植候选者中热带和外来感染的发病率。研究收集了社会人口学和临床变量、一般感染的血清学数据以及热带传染病的特异性检测数据。结果包括来自拉丁美洲(32.8%)、北非(22.4%)、撒哈拉以南非洲(14.9%)和亚洲(29.9%)的 67 名 TR 候选人。68.7%为男性,平均年龄为(48.9±13.5)岁。在进行了一般研究和特殊研究后,42 名(62.7%)患者被转诊至传染病处,以完成本研究或接受治疗。35.8%的患者患有嗜酸性粒细胞增多症,其中一例患者在研究时在粪便中检测到寄生虫。18例(26.9%)患者的强直性脊柱炎血清学检测呈阳性,而其他热带传染病的血清学检测几乎没有阳性结果。34.3% 的患者有肺结核潜伏感染。要避免 RT 术后出现严重并发症,发现和治疗这些感染至关重要。为此,从 KT 就诊开始实施跨学科筛查计划是可行、必要和有用的。
{"title":"Cribado de infecciones tropicales e importadas en candidatos a trasplante renal migrantes desde la consulta de acceso al trasplante renal","authors":"","doi":"10.1016/j.nefro.2023.10.001","DOIUrl":"10.1016/j.nefro.2023.10.001","url":null,"abstract":"<div><h3>Background and objective</h3><p>Kidney transplantation (KT) should be postponed in those people with active bacterial, fungal, viral and parasitic processes, since these must be treated and resolved previously. The objective of this study is to present the screening circuit implemented by the Nephrology clinic and describe the prevalence of tropical and imported infections in KT candidates born or coming from endemic areas.</p></div><div><h3>Materials and methods</h3><p>Descriptive cross-sectional study, carried out in 2021. Sociodemographic and clinical variables, serological data of general infections and specific tests of tropical infectious diseases were collected. A descriptive analysis of the data was carried out.</p></div><div><h3>Results</h3><p>Sixty seven TR candidates from Latin America (32.8%), North Africa (22.4%), Sub-Saharan Africa (14.9%) and Asia (29.9%) were included. 68.7% were men and the mean age was 48.9<!--> <!-->±<!--> <!-->13.5 years. After the general and specific studies, 42 (62.7%) patients were referred to the Infectious Diseases Service to complete this study or indicate treatment. 35.8% of the patients had eosinophilia, and in one case parasites were detected in feces at the time of the study. Serology for strongyloidiasis was positive in 18 (26.9%) cases, while positive serology for other tropical infections was hardly detected. 34.3% of patients had latent tuberculosis infection.</p></div><div><h3>Conclusions</h3><p>The prevalence of tropical and imported infections in migrant candidates for RT was low, except for strongyloidiasis and latent tuberculosis infection. Its detection and treatment are essential to avoid serious complications in post-TR. To this end, the implementation of an interdisciplinary screening program from the KT access consultation is feasible, necessary and useful.</p></div>","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 4","pages":"Pages 549-559"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523001522/pdfft?md5=e43fc1636d6a09e891724e474561b47e&pid=1-s2.0-S0211699523001522-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135921943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barttin en inglés, ¿y en español? 巴丁用英语,西班牙语?
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.nefro.2023.02.003
{"title":"Barttin en inglés, ¿y en español?","authors":"","doi":"10.1016/j.nefro.2023.02.003","DOIUrl":"10.1016/j.nefro.2023.02.003","url":null,"abstract":"","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 4","pages":"Pages 588-589"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523000292/pdfft?md5=2939a5de8ceeb6fc9afdc5b55613b167&pid=1-s2.0-S0211699523000292-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48066355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN 非浸润性病因晚期慢性肾病年轻患者的基因研究。GENSEN 研究设计
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.nefro.2023.09.002

Introduction

Chronic kidney disease (CKD) of unknown etiology is one of the main causes of renal replacement therapy in our environment. Previous studies in other territories suggest that hereditary diseases could be one of the potential causes of this pathology, especially in younger patients. The GENSEN study will evaluate the presence of pathogenic genetic variants in subjects who have developed CKD category G5 before the age of 46, of unknown etiology.

Methods

Observational, prospective and multicenter study, which evaluates the diagnostic usefulness of massive high-throughput sequencing (HTS) directed at a set of genes, in identifying the cause of CKD. Patients from all over Spain will be included, from whom a blood or saliva sample will be extracted, subsequently analyzing a panel of 529 genes associated with hereditary kidney disease. This publication communicates the study protocol and design.

Conclusion

The GENSEN study will allow to evaluate the diagnostic performance of a gene panel study in young subjects from our environment with the development of category G5 CKD without a clear cause. An etiological diagnosis would offer potential benefits for patients and relatives (targeted therapies, clinical trials, detection of extrarenal manifestations, evaluation of relatives for living kidney donation, estimation of the risk of recurrence in the kidney graft, genetic counseling, among others) and would allow genetic study to be brought closer to nephrology in our country.

导言:病因不明的慢性肾脏病(CKD)是我们环境中肾脏替代治疗的主要原因之一。此前在其他地区进行的研究表明,遗传性疾病可能是导致这种病症的潜在原因之一,尤其是在年轻患者中。GENSEN 研究将评估 46 岁之前患上病因不明的 G5 类慢性肾功能衰竭的受试者中是否存在致病基因变异。该研究是一项观察性、前瞻性和多中心研究,旨在评估针对一组基因的大规模高通量测序 (HTS) 在确定慢性肾功能衰竭病因方面的诊断作用。这项研究将包括来自西班牙各地的患者,从他们身上提取血液或唾液样本,然后分析与遗传性肾病相关的 529 个基因。结论 GENSEN 研究将评估基因面板研究对我们环境中无明确病因的 G5 类慢性肾脏病年轻患者的诊断效果。病因诊断将为患者和亲属带来潜在的益处(靶向治疗、临床试验、肾外表现的检测、活体肾脏捐赠亲属的评估、肾脏移植复发风险的估计、遗传咨询等),并使遗传学研究更贴近我国的肾脏病学。
{"title":"Estudio genético en pacientes jóvenes con enfermedad renal crónica avanzada de etiología no filiada. Diseño del estudio GENSEN","authors":"","doi":"10.1016/j.nefro.2023.09.002","DOIUrl":"10.1016/j.nefro.2023.09.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic kidney disease (CKD) of unknown etiology is one of the main causes of renal replacement therapy in our environment. Previous studies in other territories suggest that hereditary diseases could be one of the potential causes of this pathology, especially in younger patients. The GENSEN study will evaluate the presence of pathogenic genetic variants in subjects who have developed CKD category G5 before the age of 46, of unknown etiology.</p></div><div><h3>Methods</h3><p>Observational, prospective and multicenter study, which evaluates the diagnostic usefulness of massive high-throughput sequencing (HTS) directed at a set of genes, in identifying the cause of CKD. Patients from all over Spain will be included, from whom a blood or saliva sample will be extracted, subsequently analyzing a panel of 529 genes associated with hereditary kidney disease. This publication communicates the study protocol and design.</p></div><div><h3>Conclusion</h3><p>The GENSEN study will allow to evaluate the diagnostic performance of a gene panel study in young subjects from our environment with the development of category G5 CKD without a clear cause. An etiological diagnosis would offer potential benefits for patients and relatives (targeted therapies, clinical trials, detection of extrarenal manifestations, evaluation of relatives for living kidney donation, estimation of the risk of recurrence in the kidney graft, genetic counseling, among others) and would allow genetic study to be brought closer to nephrology in our country.</p></div>","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 4","pages":"Pages 568-575"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523001431/pdfft?md5=3967060dddaf31c18f52e96035c20879&pid=1-s2.0-S0211699523001431-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135248581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal arterial resistive index as a prognostic marker in lupus nephritis patients 肾动脉阻力指数作为狼疮性肾炎患者预后指标
IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-05-01 DOI: 10.1016/j.nefro.2023.07.003
Samir Kamal Abdul Hamid , Ashraf Elshazly , Yasser Abd Elmawgood Faisal , Kawsar Abdel Halim M.saleh , Mai Mostafa Aly

Introduction

Lupus nephritis (LN) is known to be one of the most serious complications of SLE and it is a major predictor of poor prognosis. Despite the improvement in understanding the pathophysiology of lupus nephritis and greater improvement in diagnostic approaches, lupus nephritis patients have poorer outcomes.

Objectives

Study the relation between renal resistive index (RRI) and renal function and histopathological parameters in lupus nephritis (LN) patients. Also to investigate the usefulness of RRI in predicting response to treatment.

Patients and methods

This study included 126 patients who were split into two groups (group 1: 101 LN patients and group 2: 25 SLE patients without renal affection); and 100 healthy controls (group 3). The RRI was measured for all participants through a colored Doppler ultrasound examination. LN patients underwent renal biopsy and received their therapy and were followed up for 6 months.

Results

The RRI was significantly greater in the LN group (mean ± SD; 0.64 ± 0.07) than in SLE patients without nephritis (0.5884 ± 0.04) (P < 0.0001). The RRI was greater in LN class IV (P < 0.0001). RRI significantly correlated with the chronicity index (r = 0.704, P < 0.0001), activity index (r = 0.310, P = 0.002), and serum creatinine (r = 0.607, P < 0.0001) and negatively correlated with eGFR (r = −0.719, P < 0.0001). Almost eighty-five percent (84.8%) of LN patients responded to induction therapy. RRI was significantly greater in the nonresponder group (mean ± SD, 0.73 ± 0.02) than that in the responder group (0.63 ± .07) (P < 0.0001). All non-responders to induction therapy while only 29.8% of responders had an RRI of ˃0.7. RRI, according to regression analysis was a significant predictor of response to treatment in LN patients.

Conclusion

RRI was significantly greater in the LN group and significantly correlated with kidney function and histopathological parameters. RRI can predict response to induction therapy in LN patients.

引言 众所周知,狼疮性肾炎(LN)是系统性红斑狼疮最严重的并发症之一,也是预后不良的主要预测因素。尽管人们对狼疮性肾炎的病理生理学有了进一步的了解,诊断方法也有了更大的改进,但狼疮性肾炎患者的预后仍然较差。患者和方法本研究将 126 名患者分为两组(第 1 组:101 名狼疮肾炎患者;第 2 组:25 名无肾脏疾病的系统性红斑狼疮患者)和 100 名健康对照组(第 3 组)。所有参与者都通过彩色多普勒超声检查测量了 RRI。结果 LN 组的 RRI(平均值 ± SD;0.64 ± 0.07)明显高于无肾炎的系统性红斑狼疮患者(0.5884 ± 0.04)(P < 0.0001)。LN IV 级患者的 RRI 更大(P < 0.0001)。RRI 与慢性指数(r = 0.704,P < 0.0001)、活动指数(r = 0.310,P = 0.002)和血清肌酐(r = 0.607,P < 0.0001)明显相关,与 eGFR 呈负相关(r = -0.719,P < 0.0001)。近85%(84.8%)的LN患者对诱导治疗有反应。无应答组的 RRI(平均值 ± SD,0.73 ± 0.02)明显高于应答组(0.63 ± .07)(P < 0.0001)。所有对诱导治疗无反应者的 RRI 均为˃0.7,而只有 29.8% 的反应者的 RRI 为˃0.7。根据回归分析,RRI 是预测 LN 患者治疗反应的重要指标。RRI可预测LN患者对诱导治疗的反应。
{"title":"Renal arterial resistive index as a prognostic marker in lupus nephritis patients","authors":"Samir Kamal Abdul Hamid ,&nbsp;Ashraf Elshazly ,&nbsp;Yasser Abd Elmawgood Faisal ,&nbsp;Kawsar Abdel Halim M.saleh ,&nbsp;Mai Mostafa Aly","doi":"10.1016/j.nefro.2023.07.003","DOIUrl":"10.1016/j.nefro.2023.07.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Lupus nephritis (LN) is known to be one of the most serious complications of SLE and it is a major predictor of poor prognosis. Despite the improvement in understanding the pathophysiology of lupus nephritis and greater improvement in diagnostic approaches, lupus nephritis patients have poorer outcomes.</p></div><div><h3>Objectives</h3><p>Study the relation between renal resistive index (RRI) and renal function and histopathological parameters in lupus nephritis (LN) patients. Also to investigate the usefulness of RRI in predicting response to treatment.</p></div><div><h3>Patients and methods</h3><p>This study included 126 patients who were split into two groups (group 1: 101 LN patients and group 2: 25 SLE patients without renal affection); and 100 healthy controls (group 3). The RRI was measured for all participants through a colored Doppler ultrasound examination. LN patients underwent renal biopsy and received their therapy and were followed up for 6 months.</p></div><div><h3>Results</h3><p>The RRI was significantly greater in the LN group (mean<!--> <!-->±<!--> <!-->SD; 0.64<!--> <!-->±<!--> <!-->0.07) than in SLE patients without nephritis (0.5884<!--> <!-->±<!--> <!-->0.04) (<em>P</em> <!-->&lt;<!--> <!-->0.0001). The RRI was greater in LN class IV (<em>P</em> <!-->&lt;<!--> <!-->0.0001). RRI significantly correlated with the chronicity index (<em>r</em> <!-->=<!--> <!-->0.704, <em>P</em> <!-->&lt;<!--> <!-->0.0001), activity index (<em>r</em> <!-->=<!--> <!-->0.310, <em>P</em> <!-->=<!--> <!-->0.002), and serum creatinine (<em>r</em> <!-->=<!--> <!-->0.607, <em>P</em> <!-->&lt;<!--> <!-->0.0001) and negatively correlated with eGFR (<em>r</em> <!-->=<!--> <!-->−0.719, <em>P</em> <!-->&lt;<!--> <!-->0.0001). Almost eighty-five percent (84.8%) of LN patients responded to induction therapy. RRI was significantly greater in the nonresponder group (mean<!--> <!-->±<!--> <!-->SD, 0.73<!--> <!-->±<!--> <!-->0.02) than that in the responder group (0.63<!--> <!-->±<!--> <!-->.07) (<em>P</em> <!-->&lt;<!--> <!-->0.0001). All non-responders to induction therapy while only 29.8% of responders had an RRI of ˃0.7. RRI, according to regression analysis was a significant predictor of response to treatment in LN patients.</p></div><div><h3>Conclusion</h3><p>RRI was significantly greater in the LN group and significantly correlated with kidney function and histopathological parameters. RRI can predict response to induction therapy in LN patients.</p></div>","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 3","pages":"Pages 373-381"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523001194/pdfft?md5=8cb41bcff6d05337b685541d343abd39&pid=1-s2.0-S0211699523001194-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48650285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suero salino hipertónico e insuficiencia cardiaca: ¿«sodio-centrista» o «cloro-centrista»? 高渗盐水血清与心力衰竭:“钠中心”还是“氯中心”?
IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-05-01 DOI: 10.1016/j.nefro.2023.08.006
Jaime Mazón-Ruiz , Gregorio Romero-González , Emilio Sánchez , Eduardo Josué Banegas-Deras , María Salgado-Barquinero , Luis Gutiérrez-de la Varga , José Joaquín Bande-Fernández , Manuel Gorostidi , Roberto Alcázar

Up to 50% of patients admitted for heart failure have congestion at discharge despite diagnostic and therapeutic advances. Both persistent congestion and diuretic resistance are associated with worse prognosis. The combination of hypertonic saline and loop diuretic has shown promising results in different studies. However, it has not yet achieved a standardized use, partly because of the great heterogeneity in the concentration of sodium chloride, the dose of diuretic or the amount of sodium in the diet. Classically, the movement of water from the intracellular space due to an increase in extracellular osmolarity has been postulated as the main mechanism involved. However, chloride deficit is postulated as the main up-regulator of plasma volume changes, and its correction may be the main mechanism involved. This ‘chloride centric’ approach to heart failure opens the door to therapeutic strategies that would include diuretics to correct hypochloremia, as well as sodium free chloride supplementation.

尽管诊断和治疗手段不断进步,但仍有高达 50%的心衰患者在出院时仍有充血现象。持续充血和利尿剂抵抗都与预后恶化有关。在不同的研究中,高渗盐水和襻利尿剂的联合应用显示出良好的效果。然而,这种方法尚未实现标准化使用,部分原因是氯化钠的浓度、利尿剂的剂量或饮食中的钠含量存在很大差异。一般认为,细胞外渗透压升高导致细胞内水分移动是主要机制。然而,氯化物缺乏被认为是血浆容量变化的主要上行调节因素,其纠正可能是主要的相关机制。这种 "以氯化物为中心 "的心力衰竭治疗方法为治疗策略打开了大门,治疗策略包括使用利尿剂纠正低氯血症,以及补充无钠氯化物。
{"title":"Suero salino hipertónico e insuficiencia cardiaca: ¿«sodio-centrista» o «cloro-centrista»?","authors":"Jaime Mazón-Ruiz ,&nbsp;Gregorio Romero-González ,&nbsp;Emilio Sánchez ,&nbsp;Eduardo Josué Banegas-Deras ,&nbsp;María Salgado-Barquinero ,&nbsp;Luis Gutiérrez-de la Varga ,&nbsp;José Joaquín Bande-Fernández ,&nbsp;Manuel Gorostidi ,&nbsp;Roberto Alcázar","doi":"10.1016/j.nefro.2023.08.006","DOIUrl":"10.1016/j.nefro.2023.08.006","url":null,"abstract":"<div><p>Up to 50% of patients admitted for heart failure have congestion at discharge despite diagnostic and therapeutic advances. Both persistent congestion and diuretic resistance are associated with worse prognosis. The combination of hypertonic saline and loop diuretic has shown promising results in different studies. However, it has not yet achieved a standardized use, partly because of the great heterogeneity in the concentration of sodium chloride, the dose of diuretic or the amount of sodium in the diet. Classically, the movement of water from the intracellular space due to an increase in extracellular osmolarity has been postulated as the main mechanism involved. However, chloride deficit is postulated as the main up-regulator of plasma volume changes, and its correction may be the main mechanism involved. This ‘chloride centric’ approach to heart failure opens the door to therapeutic strategies that would include diuretics to correct hypochloremia, as well as sodium free chloride supplementation.</p></div>","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 3","pages":"Pages 338-343"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523001364/pdfft?md5=cad98e5b3b656268eb81255483091125&pid=1-s2.0-S0211699523001364-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47519798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coexistence of steroid-resistant minimal change disease and familial Mediterranean fever: A case report 耐类固醇性微小病变与家族性地中海热并存:病例报告
IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-05-01 DOI: 10.1016/j.nefro.2023.09.006
Kadir Intas , Tamer Selen , Gulay Ulusal Okyay , Emine Arzu Saglam , Mehmet Deniz Ayli
{"title":"Coexistence of steroid-resistant minimal change disease and familial Mediterranean fever: A case report","authors":"Kadir Intas ,&nbsp;Tamer Selen ,&nbsp;Gulay Ulusal Okyay ,&nbsp;Emine Arzu Saglam ,&nbsp;Mehmet Deniz Ayli","doi":"10.1016/j.nefro.2023.09.006","DOIUrl":"10.1016/j.nefro.2023.09.006","url":null,"abstract":"","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 3","pages":"Pages 448-450"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523001479/pdfft?md5=6e2bd6c26ce5dfb7725e388b810f8066&pid=1-s2.0-S0211699523001479-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135388094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preeclampsia: un importante factor de riesgo de enfermedad renal crónica frecuente y desafortunadamente olvidado 子痫前期:慢性肾病的一个常见但不幸被遗忘的主要风险因素
IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-05-01 DOI: 10.1016/j.nefro.2023.06.006
Iara DaSilva Santos , Marta Ricart Calleja , Giorgina B. Piccoli
{"title":"Preeclampsia: un importante factor de riesgo de enfermedad renal crónica frecuente y desafortunadamente olvidado","authors":"Iara DaSilva Santos ,&nbsp;Marta Ricart Calleja ,&nbsp;Giorgina B. Piccoli","doi":"10.1016/j.nefro.2023.06.006","DOIUrl":"https://doi.org/10.1016/j.nefro.2023.06.006","url":null,"abstract":"","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 3","pages":"Pages 453-454"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S021169952300098X/pdfft?md5=fbd005a052347ebf182423f9956c7410&pid=1-s2.0-S021169952300098X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140818203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2 接种 SARS-CoV-2 疫苗后出现 IgA 肾病和血尿
IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-05-01 DOI: 10.1016/j.nefro.2023.11.006
Hinpetch Daungsupawong , Viroj Wiwanitkit
{"title":"IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2","authors":"Hinpetch Daungsupawong ,&nbsp;Viroj Wiwanitkit","doi":"10.1016/j.nefro.2023.11.006","DOIUrl":"https://doi.org/10.1016/j.nefro.2023.11.006","url":null,"abstract":"","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 3","pages":"Pages 455-456"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523001777/pdfft?md5=9c5646c49e72fa003a77d3944f5f00cc&pid=1-s2.0-S0211699523001777-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140818276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expresión de C4d en glomeruloesclerosis focal y segmentaria C4d在原发性局灶性和节段性肾小球硬化中的表达
IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-05-01 DOI: 10.1016/j.nefro.2023.04.005
Venice Chávez Valencia , Victoriano Pérez-Vázquez , Anel Gómez García , Katya Vargas-Ortiz , Martha Arisbeth Villanueva Pérez , Marisol Godínez Rubí , Leonardo Pazarín Villaseñor , Sergio Gutiérrez Castellanos , Citlalli Orizaga de la Cruz

Background

There is a little information about of expression of C4d (complement fragment) in focal segmental glomerulosclerosis (FSGS) subtypes. Our aim was to determine the expression of C4d in FSGS subtypes in percutaneous native renal biopsies in a second-level hospital and its correlation with clinical, biochemical and histological variables.

Material and methods

A retrospective study in paraffin blocks of patients with biopsy with FSGS aged 16-65 years, indistinct sex, not diabetic or obese. Immunohistochemistry was performed for C4d and their expression was analyzing in non-sclerosed glomerular capillaries (GC) and sclerosis areas (SA). Clinical and biochemical variables were recorded. The cases were divided into C4d positive and C4d negative groups and compared. The correlation between C4d staining scores in CG and SA with clinical and biochemical variables were analyzed.

Results

Twenty samples were analyzed, 4 for each subtype. At the time of biopsy average age was 38.8 ± 18.6 years, 65% male, 8.7% with hypertension. The percentage of positivity for C4d was 40% in GC, 30% SA and 35% in mesangium. The highest expression was for cellular and collapsing subtypes. C4d positivity cases had increased proteinuria (p = 0.035). A significant correlation was found between percentage of C4d expression in CG with SA (p = 0.012) and SA with tubular atrophy and interstitial fibrosis (p < 0.05).

Conclusions

C4d expression in FSGS predominated in the cellular and collapsing subtypes, which translates complement activation. C4d is a possible surrogate marker in GSFS.

背景关于C4d(补体片段)在局灶节段性肾小球硬化症(FSGS)亚型中的表达的信息很少。我们的目的是在一家二级医院确定经皮原位肾活检中 C4d 在 FSGS 亚型中的表达及其与临床、生化和组织学变量的相关性。对 C4d 进行免疫组化,分析其在非硬化肾小球毛细血管(GC)和硬化区(SA)的表达。此外,还记录了临床和生化变量。将病例分为 C4d 阳性组和 C4d 阴性组并进行比较。结果分析了 20 个样本,每个亚型 4 个。活组织检查时的平均年龄为(38.8 ± 18.6)岁,65%为男性,8.7%患有高血压。C4d 阳性率在 GC 中为 40%,在 SA 中为 30%,在间质中为 35%。细胞亚型和塌陷亚型的表达量最高。C4d 阳性病例的蛋白尿增加(p = 0.035)。结论C4d在FSGS中主要表达于细胞亚型和塌陷亚型,这意味着补体激活。C4d可能是GSFS的替代标志物。
{"title":"Expresión de C4d en glomeruloesclerosis focal y segmentaria","authors":"Venice Chávez Valencia ,&nbsp;Victoriano Pérez-Vázquez ,&nbsp;Anel Gómez García ,&nbsp;Katya Vargas-Ortiz ,&nbsp;Martha Arisbeth Villanueva Pérez ,&nbsp;Marisol Godínez Rubí ,&nbsp;Leonardo Pazarín Villaseñor ,&nbsp;Sergio Gutiérrez Castellanos ,&nbsp;Citlalli Orizaga de la Cruz","doi":"10.1016/j.nefro.2023.04.005","DOIUrl":"10.1016/j.nefro.2023.04.005","url":null,"abstract":"<div><h3>Background</h3><p>There is a little information about of expression of C4d (complement fragment) in focal segmental glomerulosclerosis (FSGS) subtypes. Our aim was to determine the expression of C4d in FSGS subtypes in percutaneous native renal biopsies in a second-level hospital and its correlation with clinical, biochemical and histological variables.</p></div><div><h3>Material and methods</h3><p>A retrospective study in paraffin blocks of patients with biopsy with FSGS aged 16-65 years, indistinct sex, not diabetic or obese. Immunohistochemistry was performed for C4d and their expression was analyzing in non-sclerosed glomerular capillaries (GC) and sclerosis areas (SA). Clinical and biochemical variables were recorded. The cases were divided into C4d positive and C4d negative groups and compared. The correlation between C4d staining scores in CG and SA with clinical and biochemical variables were analyzed.</p></div><div><h3>Results</h3><p>Twenty samples were analyzed, 4 for each subtype. At the time of biopsy average age was 38.8<!--> <!-->±<!--> <!-->18.6 years, 65% male, 8.7% with hypertension. The percentage of positivity for C4d was 40% in GC, 30% SA and 35% in mesangium. The highest expression was for cellular and collapsing subtypes. C4d positivity cases had increased proteinuria (p<!--> <!-->=<!--> <!-->0.035). A significant correlation was found between percentage of C4d expression in CG with SA (p<!--> <!-->=<!--> <!-->0.012) and SA with tubular atrophy and interstitial fibrosis (p<!--> <!-->&lt;<!--> <!-->0.05).</p></div><div><h3>Conclusions</h3><p>C4d expression in FSGS predominated in the cellular and collapsing subtypes, which translates complement activation. C4d is a possible surrogate marker in GSFS.</p></div>","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 3","pages":"Pages 402-407"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523000668/pdfft?md5=41ec566422d5f274f2d51233b3cfc46e&pid=1-s2.0-S0211699523000668-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42382038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nefrologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1